RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
about
Wnt Signaling in Cancer Stem Cell BiologyControl of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in CancerMouse models for the discovery of colorectal cancer driver genesHMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell nicheGene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.R-spondin 3 regulates dorsoventral and anteroposterior patterning by antagonizing Wnt/β-catenin signaling in zebrafish embryos.The Candidate Cancer Gene Database: a database of cancer driver genes from forward genetic screens in miceAbnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinomaLGR5 is associated with tumor aggressiveness in papillary thyroid cancer.PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour developmentRspo2 suppresses CD36-mediated apoptosis in oxidized low density lipoprotein-induced macrophages.Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression.RSPO2 enriches LGR5(+) spheroid colon cancer stem cells and promotes its metastasis by epithelial-mesenchymal transition.LGR5 receptor promotes cell-cell adhesion in stem cells and colon cancer cells via the IQGAP1-Rac1 pathway.Lgr6 is a stem cell marker in mouse skin squamous cell carcinoma.LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity.R-Spondin1/LGR5 Activates TGFβ Signaling and Suppresses Colon Cancer Metastasis.Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids.R-spodin2 enhances canonical Wnt signaling to maintain the stemness of glioblastoma cellsDifferential effects of spinal motor neuron-derived and skeletal muscle-derived Rspo2 on acetylcholine receptor clustering at the neuromuscular junction
P2860
Q26746101-6F2D51EA-B85A-4791-990B-E39415C325A1Q26747432-9A6199AC-D03C-434F-A831-82C2611B0BAEQ26774627-183CC546-A132-481A-A458-9FAADD64AE62Q30847630-6541B8F6-6299-4713-A2F4-EC052884B018Q35078001-D4280D3B-5F89-4999-8CD1-7FDDF362A14AQ35185403-AB992800-CD47-43E4-B5CD-86EAF2899BCBQ35254569-4D8E6045-CE07-4C2B-9A47-0CE080E0122AQ36325509-A512A533-B735-4DCF-8A1D-083F032F68B3Q36544147-BCB1875C-03F1-4C50-B72E-8E1260ECAE9BQ37263731-F13D720F-0F99-42D6-8D9A-E90AC1AF3DA3Q37297517-9035609E-BA97-4FC8-BE74-50B33733E84BQ37391989-FA55B526-20CE-465C-A179-F56A13458816Q40683197-43FCBEC8-86DF-4B79-9CA5-860799DD730EQ41408678-4BE906F1-ADFB-433E-899F-E5C37DB3A6AEQ46194866-4461ED33-8B2E-48E0-8ACB-56FEB7DFE8AEQ47391969-AAEB787D-F21C-47AE-947F-C4AF6A0E7E91Q47758650-1652EC51-9A97-4D25-AC47-9FD72FDE4546Q49237718-1E6D1425-0677-4709-9FD0-CE0D6CCF862FQ58572053-D5A43BDC-360A-4469-BEB1-DDD3DD3B850DQ58752011-ED9A1372-FEC6-4A1B-8150-8EBFA1346F37
P2860
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
@en
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
@nl
type
label
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
@en
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
@nl
prefLabel
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
@en
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
@nl
P2093
P2860
P356
P1476
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer
@en
P2093
Changjie Wu
Guangbin Luo
Haina Zhao
Hongxiao Wang
Jiajia Tang
Jiawei Zou
Ouchen Wang
Sunquan Qiu
P2860
P2888
P356
10.1038/NCOMMS4149
P407
P577
2014-01-01T00:00:00Z